drugset / Trial / NCT05652179

SGB Reduces the Incidence and Severity of CSA-AKI

NCT05652179 ↗

Completed 396 enrolled Yangzhou University
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The incidence of acute kidney injury after cardiopulmonary bypass cardiac surgery is high, which increases postoperative mortality and is not conducive to the prognosis of patients. Stellate ganglion blocks increase renal blood flow, reduce inflammation and stress, and protect the heart muscle. In this study, stellate ganglion block was used to promote rapid recovery of kidney function after cardiopulmonary bypass cardiac surgery.

Timeline

Start
2023-01-10
Primary completion
2023-12-01
Completion
2023-12-30

Drugs

EvaluationDrugModalityDoseRoute
Background Ropivacaine Other / unclassified 5 ml —

Indications

No indication recorded.